Abstract
In this study we identified two heterocyclic compounds (5 and 6) as potent and specific inhibitors of CK1δ (IC(50) = 0.040 and 0.042 μM, respectively). Whereas compound 5 exhibited fivefold higher affinity towards CK1δ than to CK1ε (IC(50) CK1ε = 0.199 μM), compound 6 also inhibited CK1ε (IC(50) = 0.0326 μM) in the same range as CK1δ. Selected compound 5 was screened over 442 kinases identifying 5 as a highly potent and selective inhibitor of CK1δ. X-ray analysis of 5 bound to CK1δ demonstrated its binding mode. In addition, characterization of 5 and 6 in a cell biological approach revealed the ability of both compounds to inhibit proliferation of tumor cell lines in a dose and cell line specific manner. In summary, our optimizations lead to the development of new highly selective CK1δ and ε specific inhibitors with biological activity.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / pharmacology*
-
Benzimidazoles / chemical synthesis
-
Benzimidazoles / pharmacology*
-
Casein Kinase 1 epsilon / antagonists & inhibitors*
-
Casein Kinase 1 epsilon / chemistry
-
Casein Kinase 1 epsilon / metabolism
-
Casein Kinase Idelta / antagonists & inhibitors*
-
Casein Kinase Idelta / chemistry
-
Casein Kinase Idelta / metabolism
-
Cell Line, Tumor
-
Cell Survival / drug effects
-
Computer Simulation
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / pharmacology*
-
Humans
-
Inhibitory Concentration 50
-
Kinetics
-
Mice
-
Models, Molecular
-
Mutation
-
Phosphopeptides / chemistry*
-
Phosphorylation
-
Quantitative Structure-Activity Relationship
-
Rats
-
Recombinant Proteins / antagonists & inhibitors
-
Recombinant Proteins / chemistry
-
Recombinant Proteins / metabolism
-
Substrate Specificity
-
Thiazoles / chemical synthesis
-
Thiazoles / pharmacology*
Substances
-
2-(2-(trifluoromethoxy)benzamido)-N-(6-(trifluoromethyl)-1H-benzo(d)imidazol-2-yl)thiazole-4-carboxamide
-
Antineoplastic Agents
-
Benzimidazoles
-
Enzyme Inhibitors
-
Phosphopeptides
-
Recombinant Proteins
-
Thiazoles
-
Casein Kinase 1 epsilon
-
Casein Kinase Idelta